One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-128302
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 8 |
Affiliation: University of Amsterdam, Academic Medical Center, Hokkaido University Hospital, Medical University of Vienna, Vienna General Hospital, University Hospital Cologne, Toranomon Hospital, University of Chicago, Kyushu University Hospital, Emory University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Oslo Cancer Cluster, Hôpital Maisonneuve-Rosemont, Université de Montréal, Peter MacCallum Cancer Centre, Royal Prince Alfred Hospital, Oregon Health & Science University, Tris Pharma (United States), James Cancer Hospital, The Ohio State University, Hospices Civils de Lyon, Hôpital Lyon Sud, University of Pennsylvania, UPMC Hillman Cancer Center, University of Michigan–Ann Arbor, Hamilton Health Sciences, Novartis (Switzerland), University of Kansas Medical Center, University of Würzburg, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Cornell University, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of MinnesotaImpact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
